EMPE’s diagnostic platform is inexpensive, easy to use and provides reliable answers about the bacterium and its resistance profile. Our multiplex molecular test indicates presence of Mycobacterium tuberculosis and its genotypic resistance profile by developing a visual signal. Clinicians can get confirmatory results in a qualitative ‘YES’ or ‘NO’ format, within 3 h. As a result, doctors will be able to select the appropriate drugs enabling effective antibiotic treatment and limit transmission of MDR-TB and save millions of patients across the world.